Emerson Electric (EMR) Tops Q4 EPS by 3c, Offers FY22 Guidance
Tweet
Share
E-mail
Get Alerts EMR Hot Sheet
Price: $164.21 --0%
Financial Fact:
Less: Noncontrolling interests in earnings of subsidiaries: 7M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Less: Noncontrolling interests in earnings of subsidiaries: 7M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Emerson Electric (NYSE: EMR) reported Q4 EPS of $1.21, $0.03 better than the analyst estimate of $1.18. Revenue for the quarter came in at $4.95 billion versus the consensus estimate of $5.09 billion.
GUIDANCE:
Emerson Electric sees FY2022 EPS of $4.82-$4.97, versus the consensus of $4.57.
- Net Sales Growth 5% to 7%
For earnings history and earnings-related data on Emerson Electric (EMR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
- DeFi Technologies Inc. (DEFT) Reports Q2 Loss of $0.04
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
